Limited dynamic range of immune response gene expression observed in healthy blood donors using RT-PCR

Molecular Medicine

Volumn 12, Issue 7-8, 2006, Pages 185-195

  McLoughlin, Kevin ^a   Turteltaub, Ken ^a   Bankaitis Davis, Danute M ^b   Gerren, Richard ^b   Siconolfi, Lisa ^b   Storm, Kathleen ^b   Cheronis, John ^c   Trollinger, David ^b   Macejak, Dennis ^b   Tryon, Victor ^b   Bevilacqua, Michael ^b  

^a LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^b Source Molecular Diagnostics (Source MDx)   (United States)

^c Paradocs Biomedical Ltd   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN;

ADULT; AGED; ARTICLE; BLOOD BANK; BLOOD DONOR; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE GENE; IMMUNOSTIMULATION; LOGLINEAR MODEL; LONGITUDINAL STUDY; MALE; METHODOLOGY; NORMAL HUMAN; PATHOPHYSIOLOGY; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; QUANTITATIVE DIAGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE TIME POINT STUDY; STANDARD DEVIATION; STATISTICAL DISTRIBUTION; STATISTICAL PARAMETERS;

ADULT; AGING; BLOOD DONORS; FEMALE; GENE EXPRESSION REGULATION; HEALTH; HUMANS; IMMUNITY; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEX CHARACTERISTICS; TIME FACTORS; VARIATION (GENETICS);

EID: 33750456201     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2006-00018.McLoughlin     Document Type: Article

References (45)

1. Bild AH et al. (2006) Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439:274-5.
2. Gladkevich A, Nelemans SA, Kauffman HF, Korf J. (2005) Microarray profiling of lymphocytes in internal diseases with an altered immune response: potential and methodology. Mediators Inflamm. 2005:317-30.
3. Han D, Leith J, Alejandro R, Bolton W, Ricordi C, Kenyon NS. (2005) Peripheral blood cytotoxic lymphocyte gene transcript levels differ in patients with long-term type 1 diabetes compared to normal controls. Cell Transplant. 14:403-9.
4. Perez EA, Pusztai L, Van de Vijver M. (2004) Improving patient care through molecular diagnostics. Semin. Oncol. 31(5 Suppl 10):14-20.
5. Baechler EC et al. (2003) Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. U. S. A. 100:2610-5.
6. Rus V, Chen H, Zernetkina V, Magder LS, Mathai S, Hochberg MC, Via CS. (2004) Gene expression profiling in peripheral blood mononuclear cells from lupus patients with active and inactive disease. Clin. Immunol. 112:231-4.
7. Chen X et al. (2002) Gene expression patterns in human liver cancers. Mol. Biol. Cell 13:1929-39.
8. Gang J et al. (2005) Discovery and analysis of pancreatic adenocarcinoma genes using DNA microarrays. World J. Gastroenterol. 11:6543-8.
9. Chang JC et al. (2003) Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet 362:362-9.
10. US patent no. 6,960,439: Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles, covering the use of a Healthy Normals Reference Dataset, issued to Source MDx, Nov. 4, 2005.
11. Stitt JT (1979) Fever versus hyperthermia. Fed. Proc. 38:39-43
12. Conti B, Tabarean I, Andrei C, Bartfai T. (2004) Cytokines and fever. Front. Biosci. 9:1433-49.
13. Dinarello CA. (2004) Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J. Endotoxin Res. 10:201-22.
14. Jiang H, Chess L (2004) An integrated view of suppressor T cell subsets in immunoregulation. J. Clin. Invest. 114:1198-1208.
15. Campbell C, Vernon SD, Karem KL, Nisenbaum R, Linger ER. (2002) Assessment of normal variability in peripheral blood gene expression. Dis. Markers 18:201-6.
16. Chowers I, Liu D, Farkas RH, et al. (2003) Gene expression variation in the adult human retina. Hum. Mol. Genet. 12:2881-93.
17. Cole J, Tsou R, Wallace K, Gibran N, Isik F. (2001) Comparison of normal human skin gene expression using cDNA microarrays. Wound Repair Regen. 9:77-85.
18. Whitney AR, Diehn M, Popper SJ, Alizadeh AA, Boldrick JC, Relman DA, Brown PO. (2003) Individuality and variation in gene expression patterns in whole blood. Proc. Natl. Acad. Sci. U. S. A. 100:1896-1901.
19. Cheung VG, Conlin LK, Weber TM, Arcaro M, Jen KY, Morley M, Spielman RS. (2003) Natural variation in human gene expression assessed in lymphoblastoid cells. Nat. Genet. 33:422-5
20. Baechler EC, Batliwalla FM, Karypis G, et al. (2004) Expression levels for many genes in human peripheral blood cells are highly sensitive to ex vivo incubation. Genes Immun. 5:347-53.
21. Debey S, Schoenbeck U, Hellmich M, Gathof BS, Pillai R, Zander T, Schultze JL. (2004) Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types. Pharmacogenomics J. 4:193-207.
22. Han ES, Wu Y, McCarter R, Nelson JF, Richardson A, Hilsenbeck SG (2004) Reproducibility, sources of variability, pooling and sample size: important considerations for the design of high-density oligonucleotide array experiments. J. Gerontol. A Biol. Sci. Med. Sci. 59:306-15.
23. Rainen L, Oelmueller U, Jurgensen S, et al. (2002) Stabilization of mRNA expression in whole blood samples. Clin. Chem. 48:1883-90.
24. Tan PK, Downey TJ, Spitznagel EL, et al. (2003) Evaluation of gene expression measurements from commercial microarray platforms. Nucleic Acids Res. 31:5676-84.
25. Snider JV, Wechser MA, Lossos IS. (2001) Human disease characterization: real-time quantitative PCR analysis of gene expression. Drug Discov. Today 6:1062-7.
26. Liles WC, Van Voorhis WC. (1995). Nomenclature and biological significance of cytokines involved in inflammation and the host immune response. j. Infect. Dis. 172:1573-80.
27. Joyce DA, Steer JH, Beilharz MW, Stranger R. (1995). A system for assessment of monokine gene expression using human whole blood. Genet. Anal. 12:39-43.
28. Inoue M, Nishimura S, Hori G, Nakahara H, Saitom M, Yoshihara Y, Amari S. (2004) Improved parameter estimation for variance-stabilizing transformation of gene-expression microarray data. J. Bioinform. Comput. Biol. 2:669-79.
29. Naef F, Hacker CR, Patil N, Magnasco M. (2002) Empirical characterization of the expression ratio noise structure in high-density oligonucleotide arrays. Genome Biol. 3(4) Epub 2002 Mar 22.
30. American Red Cross: www.redcross.org
31. Heid CA, Stevens J, Livak KJ, Williams PM (1996) Real time quantitative PCR. Genome Res. 6:986-94.
32. -δδCT method. Methods 25:402-8.
33. Pinheiro J, Bates DM. (2000) Mixed-Effects Models in S and S-PLUS. New York: Springer. 528 pp
34. R Development Core Team (2004) R Foundation for Statistical Computing, Vienna, Austria.
35. Martich G, Boujoukos A, Suffredini A (1993) Response of man to endotoxin. Immunobiology 187:403-16.
36. Schiller JS, Adams PF, Nelson ZC (2005) Summary health statistics for the US population: National health interview survey, 2003. Vital Health Stat. 10 Apr(224):1-104.
37. Koenig W et al. (1999) C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99:237-42.
38. Pearson TA et al. (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for health-care professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107:499-511.
39. Bistrian BR. (2004) Practical recommendations for immune-enhancing diets. J. Nutr. 134:28685-725.
40. Simopoulos AP. (2002) Omega-3 fatty acids in inflammation and autoimmune diseases. J. Am. Coll. Nutr. 21:495-505.
41. Eady J et al. (2005) Variation on gene expression profiles of peripheral blood mononuclear cells from healthy volunteers. Physiol. Genomics 22:402-11.
42. Radich J et al. (2004) Individual-specific variation of gene expression in peripheral blood leukocytes. Genomics 83:980-8.
43. Tryon V et al. High-precision gene expression analysis of rheumatoid arthritis and other inflammatory diseases. Int. Assoc. Inflammation Soc. Meeting Poster Presentation, Vancouver BC, August 2003.
44. Ross J et al. (2003) The HER-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy. Oncologist 8:307-25.
45. Madhusudan S, Ganesan TS (2004) Tyrosine kinase inhibitors in cancer therapy. Clin. Biochem. 37:618-35.